Inspired by a personal experience with dementia, @UTHealthSPH researcher Jiaming Liang, PhD, is helping improve care for patients and caregivers. He was recently named a 2026 Faculty Scholar by the National Institute on Aging’s IMPACT Collaboratory.
🔗 go.uth.edu/JLiang
UTHealth Houston is the first health center in Texas to offer SAINT, an FDA-approved treatment for adults with treatment-resistant depression.
Learn how a team led by João L. de Quevedo, MD, PhD, is bringing this innovative therapy to patients in Texas.
go.uth.edu/BillSAINT.
After years of navigating chronic autoimmune disease, Jennifer Capouya chose to help other patients facing similar challenges.
Her support of scleroderma research led by Zsuzsanna McMahan, MD, is helping advance new possibilities for care.
go.uth.edu/CapouyaStory
After diagnosing a rare oral cancer in a young patient, Steve Koo, DDS ’99, later received her wedding invitation—a powerful reminder of impact. Through care and philanthropy, he’s shaping the future of health. go.uth.edu/KooStory
#UTHealthHouston #HoustonsHealthUniversity
After Hurricane Harvey, Pauline Filipek, MD, helped launch a Disaster Readiness EXPO designed to make emergency preparedness more inclusive for those living with autism and neurodevelopmental disabilities. The event helped build confidence, familiarity & safety during emergencies
In this episode of Beyond the CV, Alejandro Aballay, PhD, dean of @MDA_UTHGrad, reflects on the curiosity that first drew him to science, the resilience required in research, and what it means to prepare the next generation of scientists.
🎥 go.uth.edu/BeyondAballay
How is AI changing the way we think?
In “Cognitive Revolution,” Jiajie Zhang, PhD, dean of @McWilliamsSBMI, explores how cognition extends beyond the brain and into the people, tools, and systems around us.
go.uth.edu/CognitiveRevolution
Three UTHealth Houston researchers received more than $6M in CPRIT funding to advance cancer research, treatment and prevention. The projects support training future researchers, developing next-generation therapies and studying a novel treatment approach. go.uth.edu/CPRIT6M
We’re proud to celebrate the acquisition of CrossBridge Bio by Eli Lilly, a milestone showcasing the power of academic discovery, collaboration, and innovation across Houston. Congrats to Dr. Zhiqiang An, Dr. Kyoji Tsuchikama, and everyone who helped bring this work to life.
Music and medicine came together at Doctors in Recital, where physician-musicians helped raise $5,695 for Camp PHEver, a program supporting children living with phenylketonuria.
Thank you to everyone who performed and supported this meaningful cause.
